StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
1918
This month
4
This week
3
This year
23
Today
2
Yesterday
2
Publishing Date
2024 - 04 - 24
2
2024 - 04 - 22
1
2024 - 04 - 01
1
2024 - 03 - 28
1
2024 - 03 - 27
1
2024 - 03 - 26
1
2024 - 03 - 22
1
2024 - 03 - 21
1
2024 - 03 - 04
1
2024 - 02 - 22
1
2024 - 02 - 21
1
2024 - 02 - 19
1
2024 - 02 - 12
1
2024 - 02 - 09
1
2024 - 02 - 06
1
2024 - 02 - 05
3
2024 - 01 - 19
1
2024 - 01 - 08
1
2024 - 01 - 05
1
2024 - 01 - 03
1
Sector
Distribution services
1
Electronic technology
1
Health technology
17
Manufacturing
5
Professional, scientific, and technical services
1
Technology services
1
Tags
Acquisition
696
Agreement
512
Biopharma
235
Business
935
Cancer
367
Ceo
317
Companies
249
Company
543
Conference
2588
Corporation
841
Deadline
513
Distribution
236
Earnings
260
Energy
741
Events
300
Fda
362
Financial
3316
First
2015
For
917
Global
1542
Grants
248
Group
830
Growth
1031
Health
466
International
403
Key
434
Life
263
Management
393
Market
2761
Medical
389
Meeting
617
Million
1267
N/a
29570
Nasdaq
555
Offering
670
One
261
Partnership
325
Pharma
231
Pharmaceuticals
612
Platform
294
Positive
231
Program
439
Reach
519
Report
2019
Research
860
Results
4605
Revenue
288
Sales
227
Services
408
Set
363
Solutions
447
Spac
230
Study
377
System
293
Technology
635
Therapeutics
1241
Treatment
468
Trial
459
Update
931
Year
2908
Entities
Ainos, inc.
1
Arcturus therapeutics holdings inc.
2
Arrival
1
Atea pharmaceuticals, inc.
2
Bioxytran, inc
1
Cisco systems, inc.
1
Curevac n.v.
1
Digi international inc.
1
Eli lilly and company
1
Geovax labs, inc.
2
Gritstone oncology, inc.
1
Infosys limited
1
Invivyd inc
2
Johnson & johnson
1
Koninklijke philips nv
1
Lantronix, inc.
1
Medtronic plc
1
Moderna, inc.
2
Novavax, inc.
2
Oracle corporation
1
Redhill biopharma ltd.
1
Sanofi
1
Therapeutic solutions international, inc.
1
Vaxart, inc.
1
Symbols
AIMD
1
ARCT
2
ARVL
1
AVIR
2
BIXT
1
CSCO
1
CVAC
1
DGII
1
GOVX
2
GRTS
1
INFY
1
IVVD
2
JNJ
1
LLY
1
LTRX
1
MDT
1
MRNA
2
NVAX
2
ORCL
1
RDHL
1
RYLPF
1
SNY
1
SNYNF
1
TSOI
1
VXRT
1
Exchanges
Nasdaq
22
Nyse
3
Crawled Date
2024 - 04 - 24
2
2024 - 04 - 22
1
2024 - 04 - 01
1
2024 - 03 - 28
1
2024 - 03 - 27
1
2024 - 03 - 26
1
2024 - 03 - 22
1
2024 - 03 - 21
1
2024 - 03 - 04
1
2024 - 02 - 22
1
2024 - 02 - 21
1
2024 - 02 - 19
1
2024 - 02 - 12
1
2024 - 02 - 09
1
2024 - 02 - 06
1
2024 - 02 - 05
3
2024 - 01 - 19
1
2024 - 01 - 08
1
2024 - 01 - 05
1
2024 - 01 - 03
1
Crawled Time
05:00
1
11:00
3
12:00
4
13:00
3
13:30
3
14:00
1
14:30
1
15:00
1
15:30
1
16:00
1
17:00
1
19:00
1
21:00
1
23:00
1
Source
www.biospace.com
7
www.globenewswire.com
10
www.prnewswire.com
6
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
published :
This year
tags :
Covid-19
save search
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
Published:
2024-04-24
(Crawled : 11:00)
- prnewswire.com
RDHL
|
$0.415
-2.99%
-3.08%
190K
|
Health Technology
|
-1.6%
|
O:
-3.66%
H:
0.0%
C:
0.0%
covid-19
first
study
[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19
Published:
2024-04-24
(Crawled : 05:00)
- globenewswire.com
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
0.0%
|
O:
1.78%
H:
0.0%
C:
0.0%
covid-19
sales
first
announcement
growing
roche
Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National Vaccination Campaign
Published:
2024-04-22
(Crawled : 13:00)
- biospace.com/
MRNA
|
News
S
|
$108.82
0.86%
0.85%
3.4M
|
Health Technology
|
6.39%
|
O:
1.36%
H:
2.57%
C:
1.62%
covid-19
contract
million
brazil
Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024
Published:
2024-04-01
(Crawled : 12:00)
- prnewswire.com
NVAX
|
$4.15
-0.96%
-0.96%
2.4M
|
Health Technology
|
-13.96%
|
O:
-1.03%
H:
0.62%
C:
-3.53%
covid-19
candidate
vaccine
congress
world
GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress
Published:
2024-03-28
(Crawled : 13:00)
- globenewswire.com
GOVX
|
$1.54
1.27%
35K
|
Health Technology
|
-18.95%
|
O:
4.21%
H:
1.01%
C:
1.01%
cm04
covid-19
vaccine
congress
world
Atea Pharmaceuticals Completes Patient Enrollment in Global Phase 3 SUNRISE-3 Trial Evaluating Oral Antiviral Bemnifosbuvir for COVID-19 in High-Risk Patients
Published:
2024-03-27
(Crawled : 11:00)
- globenewswire.com
AVIR
|
$3.705
-0.67%
-0.67%
200K
|
Health Technology
|
-1.06%
|
O:
3.71%
H:
3.45%
C:
2.3%
covid-19
bemnifosbuvir
antiviral
pharmaceuticals
global
trial
Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine
Published:
2024-03-26
(Crawled : 12:00)
- biospace.com/
MRNA
|
News
S
|
$108.82
0.86%
0.85%
3.4M
|
Health Technology
|
-2.26%
|
O:
1.29%
H:
0.0%
C:
-3.93%
covid-19
vaccine
positive
trial
results
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
Published:
2024-03-22
(Crawled : 19:00)
- globenewswire.com
IVVD
|
$2.13
-6.17%
-6.57%
390K
|
Manufacturing
|
Email alert
Add to watchlist
vyd222
covid-19
fda
authorization
Global Medical Device Connectivity Market Poised for Substantial Growth: In-Depth Analysis Reflects Impacts of COVID-19 and Predicts Surge through 2029
Published:
2024-03-21
(Crawled : 15:30)
- prnewswire.com
ORCL
|
News
|
$115.34
0.22%
-0.3%
5.2M
|
Technology Services
|
-10.95%
|
O:
0.99%
H:
1.73%
C:
-1.16%
MDT
|
$80.38
-1.12%
0.0%
5M
|
Health Technology
|
-3.27%
|
O:
-0.56%
H:
0.5%
C:
-0.19%
INFY
|
$17.04
-0.7%
0.0%
10M
|
Technology Services
|
-9.35%
|
O:
-3.06%
H:
0.76%
C:
-0.76%
LTRX
|
$3.23
-1.67%
-1.7%
95K
|
Distribution Services
|
-7.58%
|
O:
1.12%
H:
1.67%
C:
0.28%
DGII
|
$30.75
1.15%
1.14%
170K
|
Electronic Technology
|
2.36%
|
O:
0.98%
H:
0.77%
C:
0.37%
CSCO
|
News
|
$48.33
0.02%
0.02%
14M
|
Technology Services
|
-2.48%
|
O:
0.32%
H:
0.97%
C:
0.34%
covid-19
device
global
medical
market
Therapeutic Solutions International Granted Patent on Commercially Available QuadraMune® Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients
Published:
2024-03-04
(Crawled : 16:00)
- biospace.com/
TSOI
|
$0.0007
0.0%
23M
|
Manufacturing
|
-15.0%
|
O:
10.0%
H:
18.18%
C:
9.09%
covid-19
quadramune
patent
natural
granted
international
cell
solutions
Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase Agreement
Published:
2024-02-22
(Crawled : 11:00)
- prnewswire.com
NVAX
|
$4.15
-0.96%
-0.96%
2.4M
|
Health Technology
|
5.28%
|
O:
12.06%
H:
22.42%
C:
9.42%
covid-19
vaccine
reach
agreement
Bioxytran’s Oral Antiviral Drug to Enter Dose Optimization Clinical Trial for COVID-19
Published:
2024-02-21
(Crawled : 13:00)
- globenewswire.com
BIXT
A
|
$0.146
490.75%
120K
|
Professional, Scientific, and T...
|
28.31%
|
O:
0.0%
H:
0.09%
C:
-5.9%
covid-19
drug
antiviral
trial
Global Cruise Industry Trends Report 2024: COVID-19 Impacts, Company Case Studies, Sector Deals, Advertisement Activity, Challenges and Opportunities
Published:
2024-02-19
(Crawled : 23:00)
- prnewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
Email alert
Add to watchlist
covid-19
company
report
global
trends
Gritstone bio Announces Update to Comparative Phase 2b COVID-19 Clinical Trial
Published:
2024-02-12
(Crawled : 12:00)
- globenewswire.com
GRTS
|
$0.8199
11.01%
9.92%
1.9M
|
Health Technology
|
-67.11%
|
O:
0.89%
H:
3.42%
C:
-0.88%
covid-19
update
trial
COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
Published:
2024-02-09
(Crawled : 17:00)
- biospace.com/
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-4.69%
|
O:
-0.68%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
2.1%
|
O:
1.11%
H:
0.0%
C:
0.0%
covid-19
sales
drug
GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster
Published:
2024-02-06
(Crawled : 14:00)
- globenewswire.com
GOVX
|
$1.54
1.27%
35K
|
Health Technology
|
-39.13%
|
O:
2.77%
H:
2.69%
C:
1.92%
cm04
covid-19
vaccine
universal
geo-cm04s1
positive
trial
Ainos Submits Clinical Hold Complete Response to US FDA to Resolve the Deficiencies on Investigational New Drug Phase II Trial of its VELDONA Formulation Against Mild COVID-19 Symptoms
Published:
2024-02-05
(Crawled : 15:00)
- biospace.com/
AIMD
|
$1.03
0.98%
0.97%
50K
|
Manufacturing
|
-0.97%
|
O:
11.65%
H:
0.0%
C:
-6.09%
covid-19
fda
drug
resolve
trial
response
New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster - February 5, 2024
Published:
2024-02-05
(Crawled : 14:30)
- biospace.com/
ARCT
4
|
$27.0
-3.33%
-3.44%
270K
|
Health Technology
|
-19.56%
|
O:
-0.29%
H:
2.11%
C:
1.3%
covid-19
vaccine
mrna
therapeutics
results
New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster
Published:
2024-02-05
(Crawled : 13:30)
- prnewswire.com
ARCT
4
|
$27.0
-3.33%
-3.44%
270K
|
Health Technology
|
-19.56%
|
O:
-0.29%
H:
2.11%
C:
1.3%
covid-19
vaccine
mrna
therapeutics
results
Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
Published:
2024-01-19
(Crawled : 13:30)
- globenewswire.com
VXRT
|
News
|
$0.7051
-5.41%
-5.72%
1.5M
|
Health Technology
|
-2.49%
|
O:
2.1%
H:
1.04%
C:
-8.52%
covid-19
award
candidate
vaccine
million
nextgen
study
← Previous
1
2
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.